|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
13.500 -0.180 (-1.316%) Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| ROAA (%) | 7.116% | 6.818% | 7.071% | 10.965% | 10.734% |
| ROAE (%) | 13.807% | 14.101% | 13.556% | 17.670% | 14.093% |
| Return on Capital Employed (%) | 9.102% | 7.016% | 8.291% | 10.781% | 11.810% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Gross Profit Margin (%) | 33.800% | 35.490% | 36.520% | 35.896% | 37.325% |
| EBITDA Margin (%) | 28.756% | 25.977% | 25.310% | 32.719% | 33.733% |
| Pre-tax Profit Margin (%) | 17.036% | 15.929% | 16.232% | 25.672% | 25.701% |
| Net Profit Margin (%) | 14.609% | 13.877% | 13.389% | 22.314% | 22.837% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Current Ratio (X) | 1.801 X | 2.976 X | 1.671 X | 2.899 X | 2.796 X |
| Quick Ratio (X) | 1.686 X | 2.876 X | 1.578 X | 2.838 X | 2.731 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Total Liabilities / Total Assets(%) | 40.558% | 50.001% | 47.103% | 44.014% | 24.982% |
| Total Debt / Total Assets (%) | 24.973% | 36.627% | 29.848% | 28.740% | 8.830% |
| Net Debt / Total Assets (%) | 18.190% | 14.754% | 22.780% | 9.563% | -15.817% |
| Total Debt / Shareholders' Funds (%) | 43.875% | 78.471% | 59.096% | 53.220% | 11.854% |
| Long Term Debt / Shareholders' Funds (%) | 35.087% | 71.085% | 50.384% | 47.404% | 6.555% |
| Net Debt / Shareholders' Funds (%) | 31.958% | 31.610% | 45.104% | 17.708% | -21.235% |
| Net Cash / (Debt) ($) | (4.352B) | (3.906B) | (4.668B) | (1.759B) | 1.884B |
| Net Cash / (Debt) per share ($) | (2.458) | (2.186) | (2.613) | (0.984) | 1.581 |
| Total Debt / Capital Employed (%) | 30.327% | 42.492% | 36.891% | 34.303% | 10.592% |
| Interest Coverage Ratio (X) | 9.581 X | 11.088 X | 10.960 X | 24.004 X | 56.310 X |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Inventory Turnover (Day) | 19.140 Day | 17.827 Day | 15.214 Day | 11.874 Day | 12.808 Day |
| Receivables Turnover (Day) | 69.216 Day | 65.231 Day | 55.298 Day | 56.523 Day | 68.743 Day |
| Payables Turnover (Day) | 13.221 Day | 12.948 Day | 12.833 Day | 12.431 Day | 11.002 Day |
| Remarks: | Real time quote last updated: 30/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,793,351 |
| %Change | 12.008% |
| EPS / (LPS) | RMB 1.013 |
| NBV Per Share (¥) | RMB 7.690 |